Term: | aclacinomycin A |
|
Accession: | CHEBI:74619
|
browse the term
|
Definition: | An anthracycline antibiotic that is produced by Streptomyces galilaeus and also has potent antineoplastic activity. |
Synonyms: | exact_synonym: | methyl (1R,2R,4S)-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-4-{[2,3,6-trideoxy-4-O-{2,6-dideoxy-4-O-[(2R,6S)-6-methyl-5-oxotetrahydro-2H-pyran-2-yl]-alpha-L-lyxo-hexopyranosyl}-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl]oxy}-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate |
| related_synonym: | Formula=C42H53NO15; InChI=1S/C42H53NO15/c1-8-42(51)17-28(33-22(35(42)41(50)52-7)14-23-34(38(33)49)37(48)32-21(36(23)47)10-9-11-26(32)45)56-30-15-24(43(5)6)39(19(3)54-30)58-31-16-27(46)40(20(4)55-31)57-29-13-12-25(44)18(2)53-29/h9-11,14,18-20,24,27-31,35,39-40,45-46,49,51H,8,12-13,15-17H2,1-7H3/t18-,19-,20-,24-,27-,28-,29-,30-,31-,35-,39+,40+,42+/m0/s1; InChIKey=USZYSDMBJDPRIF-SVEJIMAYSA-N; MA 144-A1; SMILES=CC[C@@]1(O)C[C@H](O[C@H]2C[C@@H]([C@H](O[C@H]3C[C@H](O)[C@H](O[C@H]4CCC(=O)[C@H](C)O4)[C@H](C)O3)[C@H](C)O2)N(C)C)c2c(O)c3C(=O)c4c(O)cccc4C(=O)c3cc2[C@H]1C(=O)OC; aclarubicin; aclarubicina; aclarubicine; aclarubicinum |
| xref: | CAS:57576-44-0; Drug_Central:80; KEGG:C18638; KEGG:D02756; KEGG:G09914 |
| xref_mesh: | MESH:D015250 |
| xref: | MetaCyc:CPD-12960; PMID:19626543; PMID:19744710; PMID:20047095; PMID:20399885; PMID:20855424; PMID:21130493; PMID:21939347; PMID:22077238; PMID:22082134; PMID:22374527; PMID:22493369; PMID:23418619; PMID:23432721; PMID:23533247; PMID:23537708; PMID:23595277; PMID:23602475; PMID:23613979; PMID:23616245; PMID:23664707; Reaxys:4901152; Wikipedia:Aclarubicin |
| cyclic_relationship: | is_conjugate_base_of CHEBI:74353; is_tautomer_of CHEBI:77980 |
|
|